| scholarly article | Q13442814 |
| P50 | author | Antonios Mikos | Q29887911 |
| P2093 | author name string | F Kurtis Kasper | |
| Johnny Lam | |||
| Steven Lu | |||
| P2860 | cites work | Adenovirus-mediated expression of growth and differentiation factor-5 promotes chondrogenesis of adipose stem cells | Q24630416 |
| Adverse effects of adenovirus-mediated gene transfer of human transforming growth factor beta 1 into rabbit knees | Q24804324 | ||
| Intra-articular injections of high-molecular-weight hyaluronic acid have biphasic effects on joint inflammation and destruction in rat antigen-induced arthritis | Q24816854 | ||
| Biomaterial delivery of morphogens to mimic the natural healing cascade in bone | Q26996479 | ||
| Porous chitosan scaffolds with embedded hyaluronic acid/chitosan/plasmid-DNA nanoparticles encoding TGF-β1 induce DNA controlled release, transfected chondrocytes, and promoted cell proliferation | Q27310684 | ||
| Transforming growth factor-beta in calcium alginate beads for the treatment of articular cartilage defects in the rabbit | Q30310104 | ||
| Osteochondral interface tissue engineering using macroscopic gradients of bioactive signals | Q30449330 | ||
| Osteochondral interface regeneration of the rabbit knee with macroscopic gradients of bioactive signals | Q30459545 | ||
| Growth factor gradients via microsphere delivery in biopolymer scaffolds for osteochondral tissue engineering | Q30488316 | ||
| Synthesis of hydrophilic intra-articular microspheres conjugated to ibuprofen and evaluation of anti-inflammatory activity on articular explants. | Q30695013 | ||
| Overexpression of active TGF-beta-1 in the murine knee joint: evidence for synovial-layer-dependent chondro-osteophyte formation | Q32124772 | ||
| Fibroblast growth factor-2 induced chondrocyte cluster formation in experimentally wounded articular cartilage is blocked by soluble Jagged-1. | Q33502498 | ||
| Evaluating intra-articular drug delivery for the treatment of osteoarthritis in a rat model | Q33634515 | ||
| The restoration of full-thickness cartilage defects with BMSCs and TGF-beta 1 loaded PLGA/fibrin gel constructs. | Q33686537 | ||
| Autologous engineering of cartilage | Q33734579 | ||
| Supramolecular design of self-assembling nanofibers for cartilage regeneration | Q33734584 | ||
| Fibroblast growth factor-2 enhances proliferation and delays loss of chondrogenic potential in human adult bone-marrow-derived mesenchymal stem cells | Q33822806 | ||
| Effects of TGF-beta3 and preculture period of osteogenic cells on the chondrogenic differentiation of rabbit marrow mesenchymal stem cells encapsulated in a bilayered hydrogel composite. | Q33903031 | ||
| Articular cartilage proteoglycans as boundary lubricants: structure and frictional interaction of surface-attached hyaluronan and hyaluronan--aggrecan complexes. | Q33985098 | ||
| Hydrogel design for cartilage tissue engineering: a case study with hyaluronic acid. | Q34214721 | ||
| Photodegradable macromers and hydrogels for live cell encapsulation and release | Q34270035 | ||
| Synthesis of photodegradable macromers for conjugation and release of bioactive molecules | Q34344455 | ||
| Intravenous administration of anti-vascular endothelial growth factor humanized monoclonal antibody bevacizumab improves articular cartilage repair | Q34346264 | ||
| Intraarticular injection of heparin-binding insulin-like growth factor 1 sustains delivery of insulin-like growth factor 1 to cartilage through binding to chondroitin sulfate | Q34367377 | ||
| Binding and release characteristics of insulin-like growth factor-1 from a collagen-glycosaminoglycan scaffold | Q34414870 | ||
| Controlled Delivery of Transforming Growth Factor β1 by Self-Assembling Peptide Hydrogels Induces Chondrogenesis of Bone Marrow Stromal Cells and Modulates Smad2/3 Signaling | Q34447278 | ||
| Microfracture and bone morphogenetic protein 7 (BMP-7) synergistically stimulate articular cartilage repair | Q43763003 | ||
| In vitro release of transforming growth factor-beta 1 from gelatin microparticles encapsulated in biodegradable, injectable oligo(poly(ethylene glycol) fumarate) hydrogels | Q43796482 | ||
| Human mesenchymal stem cells induced by growth differentiation factor 5: an improved self-assembly tissue engineering method for cartilage repair | Q43877022 | ||
| Insulin-like growth factor-I enhances cell-based repair of articular cartilage | Q43939255 | ||
| Functional barrier principle for growth-factor-based articular cartilage repair | Q44439620 | ||
| Chondroprotective effects of high-molecular-weight cross-linked hyaluronic acid in a rabbit knee osteoarthritis model | Q44470027 | ||
| Transforming growth factor-beta 1 release from oligo(poly(ethylene glycol) fumarate) hydrogels in conditions that model the cartilage wound healing environment | Q44698554 | ||
| Comparative, osteochondral defect repair: stem cells versus chondrocytes versus bone morphogenetic protein-2, solely or in combination. | Q44951257 | ||
| Non-viral endostatin plasmid transfection of mesenchymal stem cells via collagen scaffolds | Q45291852 | ||
| Parathyroid hormone [1-34] improves articular cartilage surface architecture and integration and subchondral bone reconstitution in osteochondral defects in vivo | Q45822285 | ||
| Beneficial effects of intra-articular caspase inhibition therapy following osteochondral injury. | Q45952164 | ||
| Characterization of platelet lysate cultured mesenchymal stromal cells and their potential use in tissue-engineered osteogenic devices for the treatment of bone defects. | Q45996416 | ||
| The promotion of osteochondral repair by combined intra-articular injection of parathyroid hormone-related protein and implantation of a bi-layer collagen-silk scaffold. | Q46101687 | ||
| Stability of prostaglandin E(2) (PGE (2)) embedded in poly-D,L: -lactide-co-glycolide microspheres: a pre-conditioning approach for tissue engineering applications | Q46153110 | ||
| Dexamethasone-containing PLGA superparamagnetic microparticles as carriers for the local treatment of arthritis. | Q46168727 | ||
| Enhanced tissue integration during cartilage repair in vitro can be achieved by inhibiting chondrocyte death at the wound edge | Q46177167 | ||
| Reduced chondrogenic potential of adipose tissue derived stromal cells correlates with an altered TGFbeta receptor and BMP profile and is overcome by BMP-6. | Q46280517 | ||
| Mevastatin reduces cartilage degradation in rabbit experimental osteoarthritis through inhibition of synovial inflammation. | Q46451027 | ||
| Minocycline reduces articular cartilage damage following osteochondral injury | Q46558653 | ||
| Effect of dual growth factor delivery on chondrogenic differentiation of rabbit marrow mesenchymal stem cells encapsulated in injectable hydrogel composites. | Q46669926 | ||
| In vitro evaluation of S-(+)-ibuprofen as drug candidate for intra-articular drug delivery system | Q46749116 | ||
| Size-dependency of DL-lactide/glycolide copolymer particulates for intra-articular delivery system on phagocytosis in rat synovium | Q47191263 | ||
| Chondrogenic differentiation of adipose tissue-derived mesenchymal stem cells: greater doses of growth factor are necessary | Q47252733 | ||
| The effect of molecular weight on hyaluronan's cartilage boundary lubricating ability--alone and in combination with proteoglycan 4. | Q47358797 | ||
| Synergistic effects of growth and differentiation factor-5 (GDF-5) and insulin on expanded chondrocytes in a 3-D environment | Q47724362 | ||
| In vitro and in vivo chondrogenesis of rabbit bone marrow-derived stromal cells in fibrin matrix mixed with growth factor loaded in nanoparticles | Q47889357 | ||
| Cyclooxygenases (COX-1 and COX-2) for tissue engineering of articular cartilage--from a developmental model to first results of tissue and scaffold expression. | Q47974719 | ||
| Hyaline cartilage regeneration by combined therapy of microfracture and long-term bone morphogenetic protein-2 delivery | Q50280561 | ||
| TGF‐β3 immobilized PLGA‐gelatin/chondroitin sulfate/hyaluronic acid hybrid scaffold for cartilage regeneration | Q50441810 | ||
| Effects of transforming growth factor-β subtypes on in vitro cartilage production and mineralization of human bone marrow stromal-derived mesenchymal stem cells. | Q50546203 | ||
| Gelatin as a delivery vehicle for the controlled release of bioactive molecules | Q34464776 | ||
| Hypoxia inhibits hypertrophic differentiation and endochondral ossification in explanted tibiae | Q34490677 | ||
| Growth factor delivery-based tissue engineering: general approaches and a review of recent developments | Q34548765 | ||
| Liposomal drug delivery systems: an update review. | Q34708849 | ||
| Blocking vascular endothelial growth factor with soluble Flt-1 improves the chondrogenic potential of mouse skeletal muscle-derived stem cells | Q34786993 | ||
| Enhanced MSC chondrogenesis following delivery of TGF-β3 from alginate microspheres within hyaluronic acid hydrogels in vitro and in vivo | Q35098667 | ||
| The role of growth factors in cartilage repair | Q35209331 | ||
| Growth factor delivery through self-assembling peptide scaffolds | Q35209334 | ||
| Engineering endostatin-producing cartilaginous constructs for cartilage repair using nonviral transfection of chondrocyte-seeded and mesenchymal-stem-cell-seeded collagen scaffolds | Q35290727 | ||
| Differentiation potential of adipose derived adult stem (ADAS) cells. | Q35622969 | ||
| Engineered cartilage via self-assembled hMSC sheets with incorporated biodegradable gelatin microspheres releasing transforming growth factor-β1. | Q35803509 | ||
| Strategies for controlled delivery of growth factors and cells for bone regeneration | Q35981629 | ||
| Self-assembling nanoparticles for intra-articular delivery of anti-inflammatory proteins | Q36162174 | ||
| A review of the effects of insulin-like growth factor and platelet derived growth factor on in vivo cartilage healing and repair | Q36368761 | ||
| Synthesis of oligo(poly(ethylene glycol) fumarate). | Q36443834 | ||
| Cell-nanofiber-based cartilage tissue engineering using improved cell seeding, growth factor, and bioreactor technologies | Q36574576 | ||
| Hydrogel drug delivery system with predictable and tunable drug release and degradation rates | Q36598151 | ||
| A transduced living hyaline cartilage graft releasing transgenic stromal cell-derived factor-1 inducing endogenous stem cell homing in vivo | Q36720701 | ||
| Fibrous hyaluronic acid hydrogels that direct MSC chondrogenesis through mechanical and adhesive cues | Q36839540 | ||
| Biological impact of the fibroblast growth factor family on articular cartilage and intervertebral disc homeostasis | Q36851945 | ||
| Osteochondral tissue regeneration using a bilayered composite hydrogel with modulating dual growth factor release kinetics in a rabbit model. | Q36867889 | ||
| Cartilage repair in a rat model of osteoarthritis through intraarticular transplantation of muscle-derived stem cells expressing bone morphogenetic protein 4 and soluble Flt-1. | Q36934659 | ||
| Growth differentiation factor-5 enhances in vitro mesenchymal stromal cell chondrogenesis and hypertrophy | Q36936637 | ||
| How to achieve sustained and complete protein release from PLGA-based microparticles? | Q37046238 | ||
| Short-chain fatty acid-modified hexosamine for tissue-engineering osteoarthritic cartilage. | Q37052278 | ||
| Scaffold-based delivery of a clinically relevant anti-angiogenic drug promotes the formation of in vivo stable cartilage | Q37052301 | ||
| Growth and differentiation factors for cartilage healing and repair | Q37099565 | ||
| Systematic assessment of growth factor treatment on biochemical and biomechanical properties of engineered articular cartilage constructs | Q37137750 | ||
| Morphogenetic and regulatory mechanisms during developmental chondrogenesis: new paradigms for cartilage tissue engineering | Q37343393 | ||
| The effect of platelet-rich plasma on pain, function, and quality of life of patients with knee osteoarthritis | Q37413313 | ||
| Repair of osteochondral defects with biodegradable hydrogel composites encapsulating marrow mesenchymal stem cells in a rabbit model | Q37456078 | ||
| Bioactive factors in platelet-rich plasma obtained by apheresis | Q37513903 | ||
| Signalling molecules and growth factors for tissue engineering of cartilage-what can we learn from the growth plate? | Q37539825 | ||
| Therapeutic trajectory of hyaluronic acid versus corticosteroids in the treatment of knee osteoarthritis: a systematic review and meta-analysis | Q37641906 | ||
| Comparative review of growth factors for induction of three-dimensional in vitro chondrogenesis in human mesenchymal stem cells isolated from bone marrow and adipose tissue. | Q37701427 | ||
| Toward delivery of multiple growth factors in tissue engineering | Q37759486 | ||
| Role of proinflammatory cytokines in the pathophysiology of osteoarthritis | Q37814044 | ||
| Stromal cell-derived factor-1 (SDF-1): homing factor for engineered regenerative medicine. | Q37827159 | ||
| An update on transforming growth factor-β (TGF-β): sources, types, functions and clinical applicability for cartilage/bone healing | Q37846160 | ||
| Biomaterial-mediated delivery of microenvironmental cues for repair and regeneration of articular cartilage | Q37866282 | ||
| Chondrocytes or adult stem cells for cartilage repair: the indisputable role of growth factors | Q37893257 | ||
| The use of micro- and nanospheres as functional components for bone tissue regeneration | Q37909452 | ||
| Growth factors and chondrogenic differentiation of mesenchymal stem cells. | Q37970150 | ||
| A portrait of Transforming Growth Factor β superfamily signalling: Background matters | Q37973961 | ||
| From nano- to macro-scale: nanotechnology approaches for spatially controlled delivery of bioactive factors for bone and cartilage engineering | Q38030641 | ||
| Osteochondral tissue engineering: current strategies and challenges. | Q38061812 | ||
| Controlled release strategies for bone, cartilage, and osteochondral engineering--Part II: challenges on the evolution from single to multiple bioactive factor delivery | Q38068244 | ||
| Controlled release strategies for bone, cartilage, and osteochondral engineering--Part I: recapitulation of native tissue healing and variables for the design of delivery systems | Q38069892 | ||
| Complex articular cartilage restoration | Q38073586 | ||
| Treatment of cartilage lesions: what works and why? | Q38076858 | ||
| Transforming growth factor Beta-releasing scaffolds for cartilage tissue engineering | Q38118362 | ||
| Basic science and clinical application of platelet-rich plasma for cartilage defects and osteoarthritis: a review | Q38128123 | ||
| A chondromimetic microsphere for in situ spatially controlled chondrogenic differentiation of human mesenchymal stem cells | Q39027638 | ||
| Covalently tethered transforming growth factor beta in PEG hydrogels promotes chondrogenic differentiation of encapsulated human mesenchymal stem cells | Q39269892 | ||
| Cartilage repair by local delivery of transforming growth factor-β1 or bone morphogenetic protein-2 from a novel, segmented polyurethane/polylactic-co-glycolic bilayered scaffold. | Q39402524 | ||
| Engineering endostatin-expressing cartilaginous constructs using injectable biopolymer hydrogels | Q39647467 | ||
| In vitro stage-specific chondrogenesis of mesenchymal stem cells committed to chondrocytes | Q39889481 | ||
| Sequential release of bioactive IGF-I and TGF-beta 1 from PLGA microsphere-based scaffolds | Q40029222 | ||
| Novel scaffolds fabricated from protein-loaded microspheres for tissue engineering | Q40064677 | ||
| Dual growth factor delivery from degradable oligo(poly(ethylene glycol) fumarate) hydrogel scaffolds for cartilage tissue engineering. | Q40461948 | ||
| NELL-1 promotes cartilage regeneration in an in vivo rabbit model | Q40718621 | ||
| Development of nano- and microscale chondroitin sulfate particles for controlled growth factor delivery. | Q41770188 | ||
| TGF beta-induced cartilage repair is maintained but fibrosis is blocked in the presence of Smad7. | Q41905743 | ||
| Avidin as a model for charge driven transport into cartilage and drug delivery for treating early stage post-traumatic osteoarthritis | Q41958163 | ||
| Endogenous versus exogenous growth factor regulation of articular chondrocytes | Q41982504 | ||
| Hyaluronan injection in murine osteoarthritis prevents TGFbeta 1-induced synovial neovascularization and fibrosis and maintains articular cartilage integrity by a CD44-dependent mechanism | Q42135818 | ||
| Inhibition of HDAC activity by ITF2357 ameliorates joint inflammation and prevents cartilage and bone destruction in experimental arthritis | Q42742359 | ||
| In vivo comparison of the effects of rhBMP-2 and rhBMP-4 in osteochondral tissue regeneration. | Q42779460 | ||
| Effect of IGF-1 and Uncultured Autologous Bone-Marrow-Derived Mononuclear Cells on Repair of Osteochondral Defect in Rabbits | Q43109003 | ||
| The anti-inflammatory and matrix restorative mechanisms of platelet-rich plasma in osteoarthritis. | Q43455239 | ||
| Exogenous bFGF promotes articular cartilage repair via up-regulation of multiple growth factors. | Q50885892 | ||
| Sulforaphane-PLGA microspheres for the intra-articular treatment of osteoarthritis. | Q51059583 | ||
| Degradable hydrogel scaffolds for in vivo delivery of single and dual growth factors in cartilage repair. | Q51134667 | ||
| The amelioration of cartilage degeneration by ADAMTS-5 inhibitor delivered in a hyaluronic acid hydrogel. | Q51758630 | ||
| Infiltration of plasma rich in growth factors for osteoarthritis of the knee short-term effects on function and quality of life. | Q53065821 | ||
| The effect of platelet-rich plasma on autologous osteochondral transplantation: an in vivo rabbit model. | Q53098129 | ||
| The inductive effect of bone morphogenetic protein-4 on chondral-lineage differentiation and in situ cartilage repair. | Q53182600 | ||
| Effect of double growth factor release on cartilage tissue engineering. | Q54339408 | ||
| Cartilage-like gene expression in differentiated human stem cell spheroids: a comparison of bone marrow-derived and adipose tissue-derived stromal cells. | Q54791110 | ||
| Platelet-rich plasma intra-articular knee injections for the treatment of degenerative cartilage lesions and osteoarthritis | Q56986258 | ||
| Platelet-rich plasma: intra-articular knee injections produced favorable results on degenerative cartilage lesions | Q56988869 | ||
| Simultaneous regeneration of articular cartilage and subchondral bone induced by spatially presented TGF-beta and BMP-4 in a bilayer affinity binding system | Q56992936 | ||
| Fibroblast Growth Factor Receptors in In Vitro and In Vivo Chondrogenesis: Relating Tissue Engineering Using Adult Mesenchymal Stem Cells to Embryonic Development | Q61878667 | ||
| Induction of swelling, synovial hyperplasia and cartilage proteoglycan loss upon intra-articular injection of transforming growth factor beta-2 in the rabbit | Q68009649 | ||
| Osteoarthritis-like changes in the murine knee joint resulting from intra-articular transforming growth factor-beta injections | Q73294798 | ||
| Bioabsorbable polymer scaffolds for tissue engineering capable of sustained growth factor delivery | Q73367975 | ||
| Growth factor expression in cartilage wound healing: temporal and spatial immunolocalization in a rabbit auricular cartilage wound model | Q73998914 | ||
| Repair of articular cartilage defects: part I. Basic Science of cartilage healing | Q74522720 | ||
| Polymeric system for dual growth factor delivery | Q77106419 | ||
| Enhanced repair of extensive articular defects by insulin-like growth factor-I-laden fibrin composites | Q78165069 | ||
| Early events in cartilage repair after subchondral bone microfracture | Q78884878 | ||
| Healing of full-thickness defects of the articular cartilage in rabbits using fibroblast growth factor-2 and a fibrin sealant | Q80411926 | ||
| Overview of the fracture healing cascade | Q81270997 | ||
| Role of insulin like growth factor-I in repair response in immature cartilage | Q81481596 | ||
| Chondrogenesis of hMSC in affinity-bound TGF-beta scaffolds | Q82145805 | ||
| Spatiotemporal control over growth factor delivery from collagen-based membrane | Q82506603 | ||
| Repair of rabbit osteochondral defects by an acellular technique with an ultrapurified alginate gel containing stromal cell-derived factor-1 | Q82581160 | ||
| Liposomal targeting of glucocorticoids to the inflamed synovium inhibits cartilage matrix destruction during murine antigen-induced arthritis | Q83554311 | ||
| Development of chondroitin sulfate encapsulated PLGA microsphere delivery systems with controllable multiple burst releases for treating osteoarthritis | Q83731239 | ||
| Cartilaginous repair of full-thickness articular cartilage defects is induced by the intermittent activation of PTH/PTHrP signaling | Q84099782 | ||
| Stromal-cell-derived factor (SDF) 1-alpha in combination with BMP-2 and TGF-β1 induces site-directed cell homing and osteogenic and chondrogenic differentiation for tissue engineering without the requirement for cell seeding | Q84347109 | ||
| Repair of an osteochondral defect by sustained delivery of BMP-2 or TGFβ1 from a bilayered alginate-PLGA scaffold | Q84459553 | ||
| Dual growth factor-releasing nanoparticle/hydrogel system for cartilage tissue engineering | Q84475707 | ||
| Hylan G-F 20 maintains cartilage integrity and decreases osteophyte formation in osteoarthritis through both anabolic and anti-catabolic mechanisms | Q84585876 | ||
| Continuous gradients of material composition and growth factors for effective regeneration of the osteochondral interface | Q84680101 | ||
| Diminished cartilage-lubricating ability of human osteoarthritic synovial fluid deficient in proteoglycan 4: Restoration through proteoglycan 4 supplementation | Q84897834 | ||
| Repair of large osteochondral defects in rabbits using porous hydroxyapatite/collagen (HAp/Col) and fibroblast growth factor-2 (FGF-2) | Q84913882 | ||
| A novel method for the direct fabrication of growth factor-loaded microspheres within porous nondegradable hydrogels: controlled release for cartilage tissue engineering | Q84963556 | ||
| Repair of osteochondral defects with adipose stem cells and a dual growth factor-releasing scaffold in rabbits | Q84974355 | ||
| Phenotypic redifferentiation and cell cluster formation of cultured human articular chondrocytes in a three-dimensional oriented gelatin scaffold in the presence of PGE2--first results of a pilot study | Q86048982 | ||
| Targeted delivery to cartilage is critical for in vivo efficacy of insulin-like growth factor 1 in a rat model of osteoarthritis | Q87177493 | ||
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | cartilage | Q502730 |
| P304 | page(s) | 123-134 | |
| P577 | publication date | 2014-06-30 | |
| P1433 | published in | Advanced Drug Delivery Reviews | Q2825362 |
| P1476 | title | Strategies for controlled delivery of biologics for cartilage repair | |
| P478 | volume | 84 |
| Q90533734 | Adjuvant therapies for the enhancement of microfracture technique in cartilage repair |
| Q90259836 | Biomaterial-guided delivery of gene vectors for targeted articular cartilage repair |
| Q42319189 | Canine articular cartilage regeneration using mesenchymal stem cells seeded on platelet rich fibrin: Macroscopic and histological assessments |
| Q59112256 | Cartilage Tissue Engineering Using Combination of Chitosan Hydrogel and Mesenchymal Stem Cells |
| Q88873051 | Cartilage diseases |
| Q91795675 | Chitosan-Based Hydrogels Embedded with Hyaluronic Acid Complex Nanoparticles for Controlled Delivery of Bone Morphogenetic Protein-2 |
| Q64892008 | Chitosan-Polylactide/Hyaluronic Acid Complex Microspheres as Carriers for Controlled Release of Bioactive Transforming Growth Factor-β1. |
| Q93242135 | Enhancing chondrogenesis and mechanical strength retention in physiologically relevant hydrogels with incorporation of hyaluronic acid and direct loading of TGF-β |
| Q59335809 | Extracellular Vesicles in Joint Disease and Therapy |
| Q28083399 | Gene therapy approaches to regenerating the musculoskeletal system |
| Q98945388 | Growth Factor and Its Polymer Scaffold-Based Delivery System for Cartilage Tissue Engineering |
| Q50943279 | Honing Cell and Tissue Culture Conditions for Bone and Cartilage Tissue Engineering. |
| Q38958292 | Hydrogel-Based Controlled Delivery Systems for Articular Cartilage Repair |
| Q39067018 | Hydrogels for precision meniscus tissue engineering: a comprehensive review |
| Q47156336 | In Vivo Evaluation of Biocompatibility and Chondrogenic Potential of a Cell-Free Collagen-Based Scaffold. |
| Q57470891 | Lentiviral-based reporter constructs for profiling chondrogenic activity in primary equine cell populations |
| Q38987392 | Materials and methods for delivery of biological drugs |
| Q97519667 | Mechanically-Activated Microcapsules for 'On-Demand' Drug Delivery in Dynamically Loaded Musculoskeletal Tissues |
| Q33602314 | Nanoparticulate Mineralized Collagen Scaffolds and BMP-9 Induce a Long-Term Bone Cartilage Construct in Human Mesenchymal Stem Cells |
| Q35134897 | Overcoming transport barriers for interstitial-, lymphatic-, and lymph node-targeted drug delivery |
| Q35082006 | Positive impact of IGF-1-coupled nanoparticles on the differentiation potential of human chondrocytes cultured on collagen scaffolds. |
| Q41714074 | Silk fibroin/cartilage extracellular matrix scaffolds with sequential delivery of TGF-β3 for chondrogenic differentiation of adipose-derived stem cells |
| Q92148599 | Spatiotemporal Control of Growth Factors in Three-Dimensional Printed Scaffolds |
| Q50599085 | Sustained release effects of berberine-loaded chitosan microspheres on in vitro chondrocyte culture. |
| Q48522922 | Synthesis and characterization of polyphosphazene microspheres incorporating demineralized bone matrix scaffolds controlled release of growth factor for chondrogenesis applications. |
| Q36330063 | Technical Report: Correlation Between the Repair of Cartilage and Subchondral Bone in an Osteochondral Defect Using Bilayered, Biodegradable Hydrogel Composites |
| Q88104179 | The effect of serum types on Chondrogenic differentiation of adipose-derived stem cells |
| Q90288589 | Therapeutic effect of mesenchymal stem cells derived from human umbilical cord in rabbit temporomandibular joint model of osteoarthritis |
| Q93201537 | Three-dimensional Printing of Multilayered Tissue Engineering Scaffolds |
Search more.